(Q37803046)

23 August 2017

title

Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management (English)

1 reference

Christoph Herrmann-Lingen

23 August 2017

1 reference

1 reference

5

Christoph Herrmann-Lingen

1 reference

23 August 2017

Frieder Braunschweig

1

0 references

Susanne S. Pedersen

Susanne S Pedersen

7

0 references

Giuseppe Boriani

Giuseppe Boriani

2

0 references

Josef Kautzner

6

Josef Kautzner

1 reference

23 August 2017

10

Martin J Schalij

1 reference

23 August 2017

9

Renato Ricci

1 reference

23 August 2017

Alexander Bauer

3

1 reference

23 August 2017

Robert Hatala

4

1 reference

23 August 2017

Steen Pehrson

8

1 reference

23 August 2017

publication date

25 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

1673-1690

1 reference

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Prognostic importance of defibrillator shocks in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Atria are more susceptible to electroporation than ventricles: implications for atrial stunning, shock-induced arrhythmia and defibrillation failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Quality of life and psychological functioning of icd patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Prophylactic catheter ablation for the prevention of defibrillator therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Hazards of performing chest compressions in collapsed patients with internal cardioverter defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Electrical storm in patients with an implanted defibrillator: a matter of definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Mapping and ablation of idiopathic ventricular fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Use of thoracic epidural anesthesia for management of electrical storm: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

ICD implantation with and without combined myocardial revascularisation--incidence of ICD therapy and late survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (H

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Withdrawing implantable defibrillator shock therapy in terminally ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Management of implantable cardioverter defibrillators in end-of-life care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

The ethics of deactivating implanted cardioverter defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Primary prevention of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) tria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Randomized cross-over evaluation of two adaptive pacing algorithms for the termination of ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Haemodynamic and catecholamine response to simulated ventricular tachycardia in man: effect of baseline left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Management strategies when implanted cardioverter defibrillator leads fail: survey findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Accelerating risk of Fidelis lead fracture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Quality of life in the Canadian Implantable Defibrillator Study (CIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Quality of life with defibrillator therapy or amiodarone in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

The implantable cardioverter defibrillator: its history, current psychological impact and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Depressive coping is a predictor for emotional distress and poor quality of life in a German-Austrian sample of cardioverter-defibrillator implant recipients at 3 months and 1 year after implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Do positive health expectations and optimism relate to quality-of-life outcomes for the patient with an implantable cardioverter defibrillator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Emotional and physical precipitants of ventricular arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Psychosocial status predicts mortality in patients with life-threatening ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Cardiology Patient Page. Coping with my partner's ICD and cardiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD) A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Evaluation and management of patients after implantable cardioverter-defibrillator shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Morphology discrimination: a beat-to-beat algorithm for the discrimination of ventricular from supraventricular tachycardia by implantable cardioverter defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

Current status of the implantable cardioverter-defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ316

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUQ316

1 reference

23 August 2017

1 reference